5 results
The objective of this project is to assess the applicability of [11C]GMOM for in vivo imaging of the NMDA receptor.
* To assess the safety and tolerability of Ampligen administered intranasally in a dosing schedule for 13 days (7 doses) in healthy subjects.* To characterize the mucosal immune response following Ampligen administration over time.
To evaluate the effects of AMT-101 in combination with adalimumab on UC disease activity as measured by symptoms, endoscopy, histology, and biomarkers. To evaluate the safety and tolerability of oral AMT-101 over 8 weeksTo assess the PK parameters…
A potential reduction in pain could be obtained by the use of a thinner aspiration needle, 20 Gauge instead of 14 Gauge used right now. This is the reason for setting up a study that looks at the effect on pain perception in women by the use of a…
Phase 2:• To assess the safety, tolerability, systemic exposure, and efficacy of AMT-101 in subjects with chronic antibiotic-resistant pouchitis• To select an AMT-101 dose for Phase 3Phase 3:Co-primary Objectives:• To determine the effect of AMT-101…